Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DRick3 who wrote (11483)	7/14/1998 10:58:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

Can you post the number of shares each company holds as opposed to the outstanding? I imagine they can swap shares or issue new shares which would be dilutive but they would be adding Vivus to their assets.

To: DRick3 who wrote (11483)	7/15/1998 8:07:00 AM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

Drick3......you can look at the PE multiple of these three large phar co's 30-60 and say that if they picked up Vivus at a pe of 20 * 1999 projected earnings of $1.19,,,,$23.80 that would be an good use of their stock in a buyout . Using their stock valuation in exchange for Vivus shares. JNJ...pe 29.94 stock value $74 MRK pe 35.50 stock value $137 Pfe pe 62.70 stock value $118 Could attract other large phar co's who's stock value is at a high pe multiple .....stock value = currency in a buyout...